Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON Block in Chronic Migraine
NCT04017741Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Feb 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine, methylprednisolone in chronic migraine, sponsored by Barts Health NHS Trust. Started Feb 2018; status: completed.
02
Drugs
lidocainemethylprednisolone
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT04017741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017741.